Agios Pharmaceuticals to Present at 29th Annual J.P. Morgan Healthcare Conference

(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced that David Schenkein, M.D., chief executive officer, is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, 2011 at 11:00 AM PST at the Westin St. Francis Hotel in San Francisco.